66 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
19 Apr 24
Current report (foreign)
6:12am
of inflammatory bowel disease (IBD).8 Both UC and CD are chronic, relapsing, remitting, inflammatory conditions of the gastrointestinal tract.9,10 UC only involves
6-K
TAK
Takeda Pharmaceutical Co
9 Feb 24
Current report (foreign)
6:03am
1.
Narcolepsy is a chronic, rare neurological disorder of central hypersomnolence with significant unmet need despite multiple approved therapies
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
around ENTYVIO, including development of a subcutaneous formulation and expansion into other indications such as active chronic pouchitis. Takeda … treatments which are essential for patients with a variety of rare and complex chronic diseases. The dedicated R&D organization in PDT is charged
6-K
TAK
Takeda Pharmaceutical Co
13 Nov 23
Current report (foreign)
6:05am
and Debilitating Chronic Symptoms
Takeda Continues 70-plus Year Legacy of Driving Innovation for the Rare Hematology Community
OSAKA, Japan, and CAMBRIDGE … ADZYNMA as the first FDA-approved therapeutic option for people with cTTP.”
cTTP is an ultra-rare, chronic blood clotting disorder caused
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
(IBD) franchise around ENTYVIO, including development of a subcutaneous formulation and expansion into other indications such as active chronic … to develop life-saving plasma derived treatments which are essential for patients with a variety of rare and complex chronic diseases. The dedicated R&D
6-K
mqijf12rexnk f42i4b
28 Sep 23
Current report (foreign)
6:17am
6-K
skqvph6hc 962w3c
11 Sep 23
Current report (foreign)
6:50am
6-K
z6nj68
1 Aug 23
Current report (foreign)
6:10am
6-K
EX-99.1
oyuet
6 Jul 23
Current report (foreign)
6:18am
6-K
EX-99.1
hlin7usgnzc
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
nl2z9wvykn oz7h68g
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
bgo14hcgt
30 May 23
Current report (foreign)
6:11am
6-K
rfu80
17 May 23
Current report (foreign)
6:02am
6-K
2nqsqi7b
4 Nov 22
Current report (foreign)
6:01am
6-K
s60zo84
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
2pcn94bjs
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
3ipsmx mr
31 May 22
Current report (foreign)
6:07am
6-K
pfdq ylege
11 May 22
Current report (foreign)
6:06am